MXCT vs PFG · rev $38.6M vs P/E 16, rev $16.13B
MaxCyte Inc (MXCT) versus Principal Financial Group Inc (PFG) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PFG revenue for 2024-12-31 was $16.13B. Net income was $1.60B. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
MXCT currently screens at market cap $124.3M. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
Not investment advice. Open the MXCT and PFG stock pages for the full models.
Not investment advice.